Journal Article

Improving outcome measures in late onset Pompe disease: Modified Rasch‐Built Pompe‐Specific Activity scale

Kooten, H. A, Babačić, Haris, Tard, C., Doorn, Pieter A., Lefeuvre, C., Gracia Angarita, N., Bouibede, F., Hogrel, J. Y., Horton, Mike C., Toscano, A., Segovia, S., Mongini, Tiziana, Ploeg, Ans T., Beek, N. A. M. E., Hundsberger, Thomas, Doorn, P. A, Lefeuvre, Claire, Kooten, Harmke A., Béhin, A., Musumeci, Olimpia, Laforêt, Pascal, Babačić, H., Schoser, B., Solé, G., Spinazzi, M., Díaz‐Manera, J., Toscano, Antonio, Brusse, E., Ploeg, A. T., Taouagh, N., Hamroun, D., Wenninger, S., Wenninger, Stephan, Bouhour, F., Segovia, Sonia, Schoser, Benedikt, Beek, Nadine A. M. E., Hundsberger, T., Laforêt, P., Montagnese, F., Sacconi, S., Musumeci, O., Horton, M. C., Claeys, K.G., Díaz‐Manera, Jordi, Claeys, Kristl G., Campana‐Salort, E., Mongini, T., Brusse, Esther, Taouagh, Najib

2024

Overview

Background and purpose The Rasch‐Built Pompe‐Specific Activity (R‐PAct) scale is a patient‐reported outcome measure specifically designed to quantify the effects of Pompe disease on daily life activities, developed for use in Dutch‐ and English‐speaking countries. This study aimed to validate the R‐PAct for use in other countries. Methods Four other language versions (German, French, Italian, and Spanish) of the R‐PAct were created and distributed among Pompe patients (≥16 years old) in Germany, France, Spain, Italy, and Switzerland and pooled with data of newly diagnosed patients from Australia, Belgium, Canada, the Netherlands, New Zealand, the USA, and the UK and the original validation cohort (n = 186). The psychometric properties of the scale were assessed by exploratory factor analysis and Rasch analysis. Results Data for 520 patients were eligible for analysis. Exploratory factor analysis suggested that the items separated into two domains: Activities of Daily Living and Mobility. Both domains independently displayed adequate Rasch model measurement properties, following the removal of one item (\"Are you able to practice a sport?\") from the Mobility domain, and can be added together to form a \"higher order\" factor as well. Differential item functioning (DIF)‐by‐language assessment indicated DIF for several items; however, the impact of accounting for DIF was negligible. We recalibrated the nomogram (raw score interval‐level transformation) for the updated 17‐item R‐PAct scale. The minimal detectable change value was 13.85 for the overall R‐PAct. Conclusions After removing one item, the modified‐R‐PAct scale is a valid disease‐specific patient‐reported outcome measure for patients with Pompe disease across multiple countries.

• Publisher: John Wiley & Sons, Inc,John Wiley and Sons Inc
• Subject: Activities of Daily Living / Adolescent / Adult / Aged / daily life activities / Discriminant analysis / Factor analysis / Female / Glycogen Storage Disease Type II - diagnosis / Humans / Male / Middle Aged / Muscle and MNJ Disorders / Original / Patient Reported Outcome Measures / Patients / patient‐reported outcome measure / Pompe disease / Psychometrics - standards / Rasch analysis / Rasch model / Young Adult